Frequency and Mutation Patterns of Resistance in Patients with Chronic Hepatitis B Infection Treated with Nucleos(t)ide Analogs in Add-On and Switch Strategies


Creative Commons License

SAYAN M., AKHAN S., Senturk O.

HEPATITIS MONTHLY, cilt.11, sa.10, ss.835-842, 2011 (SCI-Expanded) identifier

Özet

Background: Treatment for chronic hepatitis B (CHB) has improved over the last 10 years mainly due to the development of effective oral antiviral agents [nucleoside/nucleotide analogs (NUCs)].